XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 29.09

-1.0%

1:28 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Robert K. who wrote (7456)	10/8/1998 6:20:00 PM
From: aknahow	Read Replies (3) of 17367

Bob, beat you!!! Discover page 92 Nov 98 "One of the most promising is a compound called BPI etc. etc. I will look for online version. Xoma is mentioned and this portion concludes "The beauty of BPI is that it not only kills bacteria but binds to endotoxin, stopping the sepsis cascade. The endotoxin is then broken down by the liver and excreted." Yes, I know there is nothing new in the article, but Bob, it's not the science it's the market. Frankly, don't know how much impact this article will have and perhaps if it is not picked up by other media it will have none. discover.com Note the November issue is not yet on line. Article is important also because of the contex as part of topic, "The New Fight Against Bacteria" "Why antibiotics are not working anymore." From top of cover. Next point is article points out why developing resistance to peptid dres in general may be more difficult and the part that deals with XOMA has two mentions of sepsis cascade. In addition BPI is the first drug mentioned under phrase some peptides are beginning the arduous trek to market.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next